Global law firm Reed Smith served as health care regulatory counsel to Webster Equity Partners and its portfolio company, Retina Consultants of America, in its entry into a definitive agreement to sell RCA to Cencora, Inc. (NYSE: COR) for approximately $4.6 billion in cash and up to $500 million in aggregate contingent consideration, provided certain predefined business objectives are met. The transaction is subject to the satisfaction of customary closing conditions, including required regulatory approvals.
Retina Consultants of America is a network of elite retina practices that provide exceptional care across the nation for macular degeneration, diabetic retinopathy, geographic atrophy and all conditions of the retina.
Founded in 2003, Webster is a private equity firm that focuses on high-impact growth strategies that seek to deliver optimal outcomes for its investors, portfolio companies and the communities that they serve. Webster’s mission is to deliver superior returns to its partners through the investment in and development of purpose-driven patient-centric health care organizations dedicated to providing best-of-class clinical care and service to their patients.
The cross-office, cross-disciplinary Reed Smith team was led by Nicole Aiken-Shaban and included Sonia Nguyen, Pete Terreri, Seb Dugmeoglu, Smita Patel, Michelle Mantine, Vicki Tankle, James Hennessy, Sarah Thompson Schick, Taber Rueter and Leah Hungerman.
Original source can be found here.